Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,397 across all filing types
Latest filing 2020-05-29 Foreign Filer Report
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
TAGRISSO DEMONSTRATED UNPRECEDENTED DISEASE-FREE SURVIVAL IN THE ADJUVANT TREATM
Foreign Filer Report
2020-05-29 English
Tagrisso unprecedented adjuvant lung cancer data
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 2932O' and is dated May 29, 2020. It details clinical trial results (Phase III ADAURA trial for Tagrisso) and includes quotes from executives and medical professionals, concluding with contact information for Investor Relations and a disclaimer stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure is characteristic of a regulatory news service announcement, which serves as a general disclosure mechanism for material information not covered by more specific SEC forms (like 10-K or ER). Since it is a broad regulatory announcement that doesn't fit perfectly into categories like Earnings Release (ER), Interim Report (IR), or Director's Dealing (DIRS), the most appropriate classification is the general Regulatory Filings category (RNS). The document length is substantial (13672 chars), but its primary function is the dissemination of material news via the RNS system.
2020-05-29 English
DIRECTOR/PDMR SHAREHOLDING
Foreign Filer Report
2020-05-26 English
Director/PDMR Shareholding
Remuneration Information Classification · 99% confidence The document is explicitly labeled with "RNS Number : 9148N" and contains details about a 'Transaction by Person Discharging Managerial Responsibilities' (PDMR), specifically the CEO being granted a share award. This type of filing, reporting insider transactions (director's dealing), is a common regulatory disclosure. While the content relates to director remuneration/share plans, the primary function of this specific RNS announcement is to report the transaction itself. The closest specific category is 'Director's Dealing' (DIRS). It is not a general regulatory filing (RNS) because a more specific category exists, and it is not a remuneration report (DEF 14A) as it only reports a single transaction, not the full compensation structure.
2020-05-26 English
ENHERTU GRANTED ORPHAN DRUG DESIGNATION IN THE US FOR GASTRIC CANCER
Foreign Filer Report
2020-05-22 English
Enhertu US orphan designation in gastric cancer
Regulatory Filings Classification · 100% confidence The document begins with 'RNS Number : 7385N' and is dated May 22, 2020. It announces a specific corporate event: 'Enhertu granted Orphan Drug Designation in the US for gastric cancer'. This type of announcement, which is a material, non-financial update released via the London Stock Exchange's news service (RNS), fits best under the general 'Regulatory Filings' category, as it is not an earnings release (ER), a full annual/interim report (10-K/IR), a management discussion (MDA), or a director's dealing (DIRS). Since it is a formal, time-sensitive regulatory announcement disseminated through RNS, the appropriate code is RNS.
2020-05-22 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.